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Abstract.  Brefeldin A  (BFA) has a profound effect on 
the structure of the Golgi apparatus, causing Golgi 
proteins to redistribute into the ER minutes after drug 
treatment. Here we describe the dissociation of a  ll0- 
kD cytoplasmieally oriented peripheral membrane pro- 
tein (Allan, V. J., and T. E. Kreis.  1986. J.  Cell Biol. 
103:2229-2239)  from the Golgi apparatus as an early 
event in BFA action, preceding other morphologic 
changes. In contrast, other peripheral membrane pro- 
teins of the Golgi apparatus were not released but fol- 
lowed Golgi membrane into the ER during BFA treat- 
ment. The ll0-kD protein remained widely dispersed 
throughout the cytoplasm during drug treatment, but 
upon removal of BFA it reassociated with membranes 
during reformation of the Golgi apparatus.  Although a 
30-s exposure to the drug was sufficient to cause the 
redistribution of the ll0-kD protein, removal of the 
drug after this short exposure resulted in the reassoci- 
ation of the 110-kD protein and no change in Golgi 
structure. If cells were exposed to BFA for 1 rain or 
more, however, a portion of the Golgi membrane was 
committed to move into and out of the ER after 
removal of the drug. ATP depletion also caused the re- 
versible release of the ll0-kD protein, but without 
Golgi membrane redistribution into the ER. These 
findings suggest that the interaction between the ll0- 
kD protein and the Golgi apparatus is dynamic and 
can be perturbed by metabolic changes or the drug 
BFA. 
T 
He Golgi apparatus  is  the central structure within 
the cell through which newly synthesized  secretory 
and membrane proteins pass, become modified, and 
are sorted en route to their final destination inside or outside 
of the cell. The striking morphology of this organdie, con- 
sisting  of ordered stacks of cisternae, reflects a  spatially 
differentiated structure that is believed to correlate with dis- 
tinct Golgi functions (lhdade,  1975; Farquhar,  1985; Dun- 
phy and Rothman,  1985). The central, perinuclear localiza- 
tion of the Golgi complex appears  to involve the direct or 
indirect interaction of this organelle with microtubules.  I.n- 
deed, this localization  is lost during mitosis when depoly- 
merization of cytoplasmic microtubules causes the break- 
down of the Golgi complex into small, dispersed clusters 
(Lucocq and Warren,  1987; Lucocq et al.,  1987). Under- 
standing how the Golgi structure is determined and main- 
tained, and how its structure relates to Golgi function, poses 
fundamental problems in cell biology. Pharmacologic per- 
turbation of the Golgi apparatus has provided a great deal of 
information about these problems.  Two types of perturba- 
tions have been observed. Drugs that disrupt microtubule  or- 
ganization such as colchicine, nocodazole,  and taxol result 
in the fragmentation and dispersion of the Golgi apparatus 
(for reviews see Thyberg and Moskalewski,  1985; Kreis, 
1990). Although these micmmbule-permrbing agents frag- 
ment the Golgi apparatus (Rogalski and Singer, 1984; 13Jrner 
and Tartakoff, 1989), they do not abrogate the identity of the 
Golgi apparatus as a distinct organelle (Ho et al., 1989), nor 
do they appreciably affect its function (Rogalski et al., 1984; 
Salas et al., 1986). In contrast, the ability of another drug, 
brefeldin A (BFA)  t, to cause the loss of the Golgi complex 
as an identifiable organelle has added a new dimension to our 
ability to perturb this structure. 
BFA is a heterocyclic lactone produced by several fungi 
(Hard et al., 1963) which dramatically alters Golgi structure 
(Fujiwara et al., 1988). This drug effectively halts secretion 
from the ER and causes the redistribution  of Golgi proteins 
into the ER (Misumi et al., 1986; Lippincott-Schwartz et al., 
1989; Doms et al.,  1989). Morphological changes in the 
Golgi apparatus  are seen within minutes after the addition 
of BFA. Initially, the cisternal structure is lost and replaced 
by swollen vacuoles that give rise to long tubulovesicular ex- 
tensions  through which Golgi  membrane and content are 
directed to the ER (Lippincott-Schwartz et al., 1990). With 
continued presence of BFA, no recognizable Golgi structure 
1. Abbreviations used in this paper: BFA, brefeldin A; Man II, mannosidase 
If; NRK, normal rat kidn~. 
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This is accompanied by a cessation of anterograde  transport 
from the ER/Golgi complex to more peripheral organelles. 
These dramatic  effects of BFA are rapidly and completely 
reversed by removing the drug.  We know of no other drug 
with a  similar  effect on the existence of a  particular  or- 
ganelle.  Understanding  how BFA acts will likely shed light 
on the process of biogenesis of organelies and on the ability 
of eukaryotic cells to establish the highly differentiated state 
of membrane-bounded compartmentalization. 
One  potential  mechanism  by which  BFA could act  is 
through the disruption of underlying  structural  elements  of 
the Golgi apparatus,  To explore this possibility further we 
examined the effect of BFA on several cytoplasmically ori- 
ented proteins associated with the Golgi apparatus.  These in- 
clude (a) a  ll0-kD protein, described by Allan  and Kreis 
(1986), that associates with the Golgi complex as a cytoplas- 
mically oriented peripheral membrane protein and has been 
proposed to be a structural  element that might mediate the 
interaction of the Golgi apparatus with microtubules since it 
interacts  with taxol-stab~  microtubules in vitro; (b) a 
58-kD protein,  distinct  from the ll0-kD protein, that also 
localizes to the cytoplasmic face of the Golgi apparatus  and 
binds to microtubules in vitro (Bloom and Brashear [1989]); 
and (c) two cytoplasmically oriented peripheral Golgi mem- 
brane proteins of 54 and  86 kD recognized by the mAb 
6F4C5  (Chicheportiche  et al.,  1984). 
In this report we show that the ll0-kD protein dissociates 
from the Golgi complex within  30 s after the addition  of 
BFA. This precedes any other morphologic change observ- 
able at the light microscopic level. Removal of the drug after 
these short times results in the rapid re.association of the pro- 
tein with theGolgi apparatus and the direct recovery of Golgi 
structure.  If, however, cells are exposed to BFA for 1 min 
or longer, a portion of the Golgi apparatus  is committed to 
move into the ER, even after the removal of the drug. In con- 
trast, the 58-kD protein and the two peripheral membrane 
proteins recognized by 6F4C5 are not released in response 
to BFA. The rapid dissociation  of the ll0-kD protein from 
the Golgi apparatus  upon treatment with BFA suggests this 
is an early event in the action of  BFA preceding the disassem- 
bly of the Golgi apparatus. 
Materials and Methods 
Materials and Cell Culture 
BFA was obtained from Sandoz Ltd. (Basel,  Switzerland)  and Epicentre 
Technologies (Madison, WI) and was stored at -20°C as a stock solution 
of 5 mg/mi in me~nul. Nocodnzole was purchased from Sigma Chemical 
Co.  (St. Louis, MO) and where indicated was used at 20/~g/mi. Normal 
rat  kidney (NRK) cells  were maintained in  RPMI supplemented with 10% 
FCS and  0.3% gantamycin at  37°C in  5% CO2. Cells  were  plated  onto 12- 
mm-dlam glass coversllps  48 h before experiments. 
Antibodies 
A rabbit IgG directed against Golgi mannosidase II (Man 11) (Moremen and 
Touster, 1985) was generously supplied by Dr. K. Moremen (Massachusetts 
Institute of Technology, Boston, MA). The mouse mAb M3AS, character- 
ized by Allan and Krois (1986),  recognizes the llO-kD Golgl peripheral 
membrane protein, and the mouse monoclonal antibody (clone 9) recog- 
nizes the 58-kD peripheral Golgi membrane protein (Bloom and Brashear, 
1989). The mAb C6F4C,  which recognizes two peripheral Golgi proteins 
of  54,000  and  86,000  Mr  (Chicheportiche et  al.,  1984),  was  kindly 
provided by Dr. A. Tartakoff (Case-Western Reserve University, Cleveland, 
OH). Rhodaminer and fluorescein-labeled  goat anti-mouse and goat anti- 
rabbit IgG were purchased from Orgsnon Teknika (Westchester,  PA) and 
used at 1:500 dilution of manufacturer's stock solution. 
Immunofluorescence  Microscopy 
Cells on coversllps were incubated with the appropriate drugs in culture me- 
dia before immunofluorescenr.,e assay. Cells were then fixed for 10 min at 
room temperature in 2 % formaldehyde in  PBS. After washing the fixed cells 
in PBS, the cells were permeabllized by submersion in methanol at 0°C for 
1.5 rain and then placed in PBS containln~ 10% FCS. Cells were incubated 
with primary antibodies in PBS/10%  FCS and 0.15%  sapunin for  1 h, 
washed free of antibody, and then incubated in the fluorescentiy labeled sec- 
ond antibodies for 1 h. After washing,  coverslips  were mounted on slides 
in Fhiormount G (Southern Biotochnology Associates,  Birmingham, AL), 
and viewed with a 63× oil Planapo lens on a Zeiss microscope equipped 
with barrier filters  to  prevent crossover  of fluorescein  and rhodamine 
fluorescence. 
Results 
BFA Causes the HO-kD  Protein to Dissociate  from the 
Golgi Apparatus 
We have previously shown that BFA causes the rapid redistri- 
bution of Golgi resident proteins into the ER, resulting  in 
the  loss  of the  Golgi  apparatus  as  a  distinct  organelle 
(Lippincott-Schwartz  et al., 1989). While the mechanism of 
action of BFA is far from understood, recent data suggest 
that the earliest effects of BFA occur at the level of the Golgi 
apparatus  (Lippincott-Schwartz  et al.,  1990).  To test this 
possibility further we examined  the effect of BFA on the 
cytoplasmically oriented ll0-kD Golgi-associated  protein, 
believed to be a structural component of the Golgi apparatus 
(Allan and Kreis, 1986). As shown in Fig. 1, immunoflnores- 
cence staining of  permeabilized NRK ceils using an antibody 
to the  ll0-kD  protein  revealed  labeling  of a  perinuclear 
structure typical of the Golgi complex in these cells. While 
this staining pattern overlapped significantly with that for the 
cis/medial-Golgi integral membrane protein, Man II, there 
were slight differences. For instance, whereas Man H was as- 
sociated in a tightly  packed structure,  the l l0-kD protein 
was more loosely associated, appearing to envelop the Golgi 
apparatus. In addition, the ll0-kD protein was also localized 
to peripheral vesicles not labeled with Man II, as was ob- 
served previously (Allan and Kreis,  1986). 
Addition of  BFA to cells had a dramatic effect on the distri- 
bution of the ll0-kD protein. Within 30 s after adding BFA, 
the ll0-kD protein was no longer predominantly  associated 
with the Golgi apparatus,  but instead appeared widely dis- 
persed throughout  the cytoplasm. Double-labeling of these 
cells with antibodies  to Man II,  however,  showed that at 
these early times no change in Golgi structure by light mi- 
croscopy was apparent.  It was not until 2 rain of BFA treat- 
ment that  the Man H staining pattern began to  alter.  The 
earliest changes included the extension of beaded, necklace- 
like tubular processes from the Golgi apparatus  which carry 
Golgi proteins into the ER. By 15 rain, there was no discer- 
nable Golgi structure.  Instead,  Golgi resident proteins,  as 
visualized  by Man H  staining,  were distributed in a  fine 
punctate/reticular pattern that we have shown previously by 
immunoelectron microscopy and biochemical techniques in- 
dudes their distribution  within the ER (Lippincott-Schwartz 
et al., 1989). Throughout BFA treatment,  the 110-kD protein 
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association of  the ll0-kD pro- 
rein with the Golgi apparatus. 
NRK cells were treated with- 
out (Control)  or with 5 t~g/ml 
(18/~M) BFA at 37°C for the 
indicated times and then fixed, 
permeab~,  and  stained 
by double-iahel  immunofluo- 
rescence  with  antibodies  to 
the  llO-kD protein  and Man 
H.  In  control  cells  Man  H 
staining  was  confined to  a 
compact perinuclear structure 
typical of  Golgi distribution in 
these  cells.  The l l0-kD pro- 
tein colocalized with the Man 
H staining pattern enveloping 
the Man H-stained Golgi ap- 
paratus, with additional stain- 
ing of peripheral vesicles. 30 s 
after the addition of BFA, the 
ll0-kD  protein  was  widely 
scattered throughout the cyto- 
plasm, while the Golgi appa- 
ratus  structure  remained  in- 
tact.  After 2 min of treatment 
the  Golgi  apparatus,  labeled 
with antibodies to Man H, was 
beginning to extrude necklace- 
like  processes  (arrow),  evi- 
dence that the BFA-induced re- 
distribution  of Golgi proteins 
back to the ER had begun. By 
15 min that redistribution was 
completed  as  there  was  no 
recognizable  Golgi structure. 
Instead,  Man II was distrib- 
uted  in  a  punctate/reticular 
pattern  characteristic  of ER 
staining.  The llO-kD protein 
remained  widely  scattered 
throughout the cytoplasm  dur- 
ing BFA treatment and not co- 
localized  with  Man II distri- 
bution.  Bar, 10/zm. 
remained widely dispersed throughout  the cytoplasm.  No 
obvious colocalization of the  ll0-kD  protein and  Man II 
could be observed after 15 rain of BFA treatment. Indeed, 
Man II staining in BFA-treated cells was more concentrated 
in regions around the nucleus as was observed for an anti- 
body to an ER resident protein (Louvard et el.,  1982) (data 
not shown), while staining of the  ll0-kD protein extended 
out into the periphery, to the edges of the cytoplasm. During 
BFA treatment the 110-kD protein staining often appeared as 
a  diffuse  cytoplasmic fluorescence  with  regions  of small 
punctate aggregates but at no time was it colocalized with 
micrombules (data not shown). Similar effects of BFA on the 
ll0-kD protein and Golgi structure were observed in other 
cell types, including HeLa and Vero cells (data not shown). 
Release of the ll0-kD protein could be detected as early 
as 20 s after BFA addition. At these early times of BFA treat- 
ment (up to 1 min) the extent of dissociation of the 1  lO~kD 
protein varied somewhat from cell to celL=with ~many cells 
showing some residual  ll0-kD protein associated with the 
Golgi complex. In all cells examined, however, after 2 rain 
of BFA trealment,  no  ll0-kD protein remained associated 
with Golgi structures. 
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Other Known Peripheral Golgi Membrane Proteins 
To determine whether the BFA-induced dissociation of the 
110-kD protein was specific for this protein or was a result 
of  a general response of  the Golgi membrane to the drug, we 
examined the effect of  BFA on other cytoplasmically oriented 
peripheral  Golgi membrane proteins.  The effect of BFA on 
the distribution of two reported peripheral Golgi membrane 
proteins  of 54,000  and 86,000 Mr recognized by the mAb 
6F4C5 (Chicbeportiche et al., 1984) is shown in Fig. 2. Im- 
munofluorescence staining of one or both of these proteins 
was superimposable with staining of Man IT fluorescence in 
control cells and in cells treated with BFA (Fig. 2, bottom 
row). A 58-kD Golgi-associated protein has been described 
with properties  similar to the 110-kD protein.  This protein 
specifically  colocalizes  with the Golgi  apparatus  by im- 
munofluorescence and is capable of binding to polymerized 
microtubules in vitro (Bloom and Brashear,  1989). In con- 
trast to the ll0-kD protein, however, BFA did not cause the 
dissociation of the 58-kD protein from the Golgi complex. 
The 58-kD protein  fluorescence remained associated  with 
Man 1I distribution, colocalizing with Man II in Golgi struc- 
tures in control cells; and during BFA treatment fluorescence 
remained associated with Golgi proteins (Fig. 2, middle row) 
both before and during their redistribution into the ER. Like 
the  proteins  recognized  by  6F4C5, the  58-kD  protein 
colocalized  with Man II along  tubular  extensions  of the 
Golgi complex after 2 rain of BFA treatment. Thus the ll0- 
kD  protein,  to  the  extent  so  far  examined,  is  uniquely 
affected by BFA treatment. 
Effect of  BFA Dose on the Kinetics of IIO-RD Protein 
Dissociation and Movement of  Man H into the ER 
In the above experiments we used a relatively high concen- 
tration of  BFA (5/~g/ml) to demonstrate that the dissociation 
of the ll0-kD protein preceded the redistribution of Man 1I 
into the ER. To determine whether lower concentrations of 
BFA were capable  of inducing a  complete  BFA response 
(i.e., dissociation of  the ll0-kD protein and redistribution of 
Golgi components to the ER), we looked at the dose depen- 
dency of  this process. As shown in Fig. 3, after 5 rain of  incu- 
bation with the low dose of 0.1 ~tg/ml  of BFA, there was no 
observable change in either Golgi structure, as visualized by 
Man II or in the association of  the 110-kD protein, compared 
with control cells (compare Figs. 1 and 3). It was not until 
after a 10-min incubation at this dose, when tubulovesicular 
Golgi processes appeared (arrow), that a partial dissociation 
of the  ll0-kD protein  from the Golgi apparatus  was ob- 
served.  The ll0-kD protein  was never observed to be as- 
sociated with these tubular  Golgi extensions,  however. In 
contrast,  incubation  of cells  for 5 rain  in  1.0  ~tg/ml BFA 
resulted in complete dispersal of  the 110-kD protein through- 
out the cytoplasm, even though Man II labeling of remnant 
Golgi structures could still be observed.  By 10 min, all of 
the Man II staining appeared in a diffuse punctate network 
with no Golgi structures visible. The rate of these changes 
in Golgi structure induced by 1.0 #g/ml BFA was similar to 
that observed with 5 ~g/ml (compare Figs. 1 and 3). Thus, 
at BFA concentrations ;*1/~g/ml, the kinetics of dissociation 
of  the 110-kD protein from the Golgi complex, and the redis- 
tribution  of Golgi membrane  into the ER appeared  to be 
maximized. Intermediate doses of BFA (0.3/~g/rul) resulted 
in intermediate  kinetics for the rate of dissociation  of the 
110-kD protein and redistribution of Golgi complex mem- 
brane.  The overall pattern demonstrated  that lowering the 
dose of BFA results in the slowing of both the release of the 
ll0-kD protein and of the Golgi protein redistribution into 
the ER. Extendin~ the period of  incubation with BFA showed 
that the times required to totally redistribute Man II into the 
ER, defined by the absence of  any Golgi structure, were 5-10 
min for 1.0 ~g/ml, 15 mill for 0.3 ~g/ml, and 25-30 rain for 
0.1 ttg/mi BFA. Importantly, regardless of the time required 
to translocate Golgi complex proteins into the ER, the final 
phenotype in each case resembled that seen with high doses 
of BFA; i.e., Man II in a punctate distribution characteristic 
of ER and the 110 kD-protein widely scattered throughout 
the cytoplasm (Fig.  1). 
The llO-kD Protein Reassociates with Golgi Membrane 
upon Removal ofB  FA 
While the  l l0-kD protein  appears  to remain  dissociated 
from the Golgi membrane in the presence of  BFA, once BFA 
is removed,  the  110-kD protein  rapidly reassociates  with 
Golgi membrane as this membrane reforms a Golgi appara- 
tus. This is shown in Fig. 4 where NRK cells that had been 
treated with BFA for 30 min were rinsed twice with culture 
media to remove BFA, and then incubated at 37°C before 
double immunolabeling with antibodies to Man II and the 
110-kD protein.  Movement of the ll0-kD protein from the 
periphery in toward the location of  Golgi membrane proteins 
could  be detected within minutes after drug removal, and the 
extent of re.association of the 110-kD protein with the Golgi 
apparatus  increased with the time of recovery. By 5 min, 
Man II staining began to accumulate in discrete vesicles that 
weakly  colocalized  with  the  ll0-kD  protein  (data  not 
shown). By 10 min these structures had enlarged and tubular- 
like structures were also stained both with the antibodies to 
the ll0-kD protein and Man R. After 30 rain these structures 
and the associated  ll0-kD protein had condensed to form 
recognizable Golgi elements which by 60 rain had become 
more compact, resembling the Golgi apparatus in untreated 
NRK cells. 
Figure 2. The BFA-induced  dissociation  is specific  to the 110-kD Golgi  protein. Ceils  were incubated at 37°C in the absence (CONTROL) 
or presence of  5 ~g/ml  BFA for 2 rain  before  fixation,  permeabilization,  and preparation for indirect  immunofluorescence.  Cells  were  double 
labeled with antibodies  to Man H and either  the 110- or the 58-kD protein, or 6F4C5, a mAb that recognizes  two (a 54- and 86-kD) periph- 
eral membrane  Golgi  proteins. In control  cells  all of  the Golgi-associated  proteins (i.e., the 110- and 58-kD proteins  and 6F4C5) colocalized 
with Man H staining. After 2 min of BFA treatment, however, only  the ll0-kD protein  was released from the Golgi apparatus and found 
in a widely scattered diffuse  distribution. The 58-kD protein remained associated with Golgi elements during BFA treatment. The 54- 
and 86-kD proteins recognized  by 6F4C5 also remained  with Golgi  elements during  BFA treatment, and were observed colocalized  with 
Man H-stained Golgi and tubular extensions (arrows) of the Golgi complex. Bar, 10 ~m. 
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Short BFA Treatment 
Dissociation of the ll0-kD protein from the Golgi apparatus 
is the earliest event so far detected during BFAtreatment; oc- 
curring before any noticeable redistribution of Golgi mem- 
brane into the ER. Since we know that the lt0-kD protein 
can rapidly re~sociate with Golgi membrane once BFA is 
removed, we examined the fate of the Golgi apparatus using 
the marker Man II and the ll0-kD protein in cells treated 
with BFA for 1 rain and then wnshed free of the drug. As 
shown in Fig. 5, after 1 min of BFA treatment, Man lI stain- 
ing of the Golgi apparatus appeared similar to untreated 
cells, even though the 110-kD protein was widely scattered 
throughout the cytoplasm. 5 rain after removing BFA, Man 
II was no longer restricted to its original morphology or lo- 
cation but appeared to be present to a significant amount in 
punctate/reticular pattern  consistent with  its  presence  in 
the ER.  The ll0-kD protein colocalized with these Man 
H-stained  structures.  These results  suggest that brief ex- 
posure to BFA is sufficientto commit Man II and other Golgi 
proteins to follow the pathway into the ER after the BFA is 
removed. Then, 15 rain after the removal of BFA, Man 1I 
staining was again associated with large, perinuclear, cister- 
nal-like structures. This rapid recovery into enlarged Golgi- 
like structures after 1 rnin BFA exposure is in contrast to 
recovery after longer exposures to BFA (as in Fig. 4). 
The commitment of Golgi membrane to move into the ER 
required at least 1 min of  BFA treatment. A striking contrast 
was seen with shorter treatments of BFA. When ceils were 
treated with 5/~g/ml BFA for 30 s the 110-kD protein was 
widely distributed throughout the cytoplasm as observed in 
Fig. 1. However, when BFA was removed after the 30-s incu- 
bation, no detectable Man II appeared to cycle through the 
ER. 5 min after removal of BFA, the staining patterns of the 
ll0-kD protein and Man II colocaliTed, resembling that ob- 
served in control cells. At no time, during recovery times of 
up to 3 h after 30 s of BFA treatment, was Man II observed 
in tubular structures of the Golgi apparatus or in a diffuse 
punctate pattern characteristic of the ER (data not shown). 
Thus, despite significant release of the ll0-kD protein after 
30 s of BFA, Golgi membrane was not irreversibly commit- 
ted to move into the ER before reforming the Golgi appara- 
tus.  The length of BFA treatment required to commit the 
Golgi proteins to move into the ER during recovery was cor- 
related with dose. For example, while 1 rain of exposure was 
sufficient for doses of BFA between 1 and 5 ttg/ml, 5 win 
of exposure  was  necessary at  0.3  /zg/ml  BFA  (data  not 
shown). 
ATP was required during these short BFA treatments in or- 
der to commit Golgi membrane to move into the ER. When 
cells were pretreated with ATP-depleting media, containing 
50 mM deoxyglucose  and 0.05 % sodium azide, for 5 min be- 
fore addition of BFA for 1 or 2 rain, and then washed and 
incubated in drug-free complete media,  no movement of 
Golgi membrane into the ER was observed (data not shown). 
Low Temperature and Microtubule Disruption 
Inhibit the BFA-induced Redistribution of  Man H But 
Not the Dissociation  of the llO-kD Protein 
The BFA-induced transport of  Golgi proteins into the ER can 
be  inhibited  by low  temperature  and  agents  that  disrupt 
microtubules (Lippincott-Schwartz et ai., 1990). To further 
distinguish the dissociation of the 110-kD protein from sub- 
sequent BFA-induced morphologic events we tested the effect 
of reduced temperatures and mierotubule inhibitors on the 
BFA-induced dissociation of  the ll0-kD protein (Fig. 6). Af- 
ter 1 h at 16"C in the absence of BFA the ll0-kD protein 
staining remained associated with the Golgi apparatus and 
appeared identical to cells at 37"C. But after adding BFA to 
these cells at 16"C the ll0-kD protein was released from the 
Man H-stained Golgi complex which remained intact except 
for a few tubular extension structures similar to what was ob- 
served after 2 rain BFA at 37"C. Thus the reduced tempera- 
ture did not block the BFA-induced release of the  ll0-kD 
protein but did inhibit Man II redistribution into the ER. 
Removal Of  BFA from these cells at 160C, followed by raising 
the temperature to 370C,  demonstrated that the Golgi pro- 
teins bad been committed to follow the recycling pathway 
back to the ER and then out again to reform the Golgi ap- 
paratus during postdrug incubation (data not shown) as was 
observed in Fig. 5. 
Two microtubule-disrupting agents, nocodazole  and griseo- 
fulvin,  were used to  study the effect of microtubules on 
the association of the 110-kD protein with the Golgi appara- 
tus. Nocodazole treatment resulted in the expected fragmen- 
tation of the Golgi complex but the maintenance of the as- 
sociation of the ll0-kD protein with the Golgi fragments, as 
had been reported by Allan and Kreis (1986). The addition 
of BFA to nocodazole-treated cells failed to result in the 
redistribution to the ER of Man H which remained in the 
fragmented Golgi structures. However, nocodazole did not 
inhibit the release of the ll0-kD protein induced by BFA as 
it was found diffusely throughout the cytoplasm (Fig. 6). The 
use of griseofulvin in place of nocodazole resulted in the 
same observations. Recovery of such BFA-treated cells into 
nocodazole-containing media  resulted in the  rapid  (5-10 
min) reassociation of  the 110-kD protein with the Golgi frag- 
ments; incubation in media alone, which would allow for the 
reformation of mierotubules, resulted in Golgi reformation, 
but it was difficult to determine whether the Golgi apparatus 
Figure 3. Effect of BFA concentration on the ll0-kD protein dissociation and movement of Man II into the ER. NRK ceils were treated 
with BFA at (3.1, 0.3, or 1.0/~g/ml (0.36, 1.07, and 3.57 aM, respectively) for either 5 or 10 rain before fixation, permeabilization, and 
staining for immunofluorescence. At the low dose of 0.1 ttg/ml, the labeling of the ll0-kD protein colocalized with the Man H-stained 
Golgi structure after 5 min, while after 10 rain at this dose there was a partial release of the llO-kD protein from the Golgi complex, 
and tubular extensions from the Golgi complex carrying Golgi proteins into the ER were now evident (arrow). At 1.0 ttg/ml the time course 
of  the 110-kD protein dissociation and BFA-induced  Man II redistribution paralleled that seen in Fig. 1 with 5 #g/ml. By 5 rain of  incubation 
all of  the ll0-kD protein was widely dispersed throughout the cytoplasm while most of  the Man II labeling was distributed in an ER pattern, 
although some remnant Golgi structure and tubular processes remained. By 10 rain at this dose, however, all of the Man II labeling was 
distributed in a ptmctate/reticular pattern consistent with an ER location while the 110-kD protein remained widely scattered to the far 
edges of the cell. Bar, 10/tm. 
Donaldson et al. BFA-induced  Dissociation of 110-kD Golgi Protein  2301 Figure 4. Reassociation  of  the 110-kD protein with the Golgi  membrane during recovery  after BFA. NRK cells were first treated with 5 #g/ml 
(18 #M) BFA for 30 min at 37°C, then rinsed at 37°C with three 1-ml changes of media before incubation in 1 ml of fresh media at 37°C 
for0,  10, or 30 min. By 10 min of recovery the ll0-kD protein colocalized with nearly all of the Man H-labeled enlarged structure and 
associated interconnecting strands located outside of the ER. By 30 rain of recovery Man lI localized to condensing Golgi elements sur- 
rounding the nucleus that colocalized with the ll0-kD protein. Bar,  10/an. 
The Journal of Cell Biology,  Volume ! 11, 1990  2302 Figure 5.  Golgi proteins are committed to enter the ER after 1 rain of BFA treatment. NRK cells were treated  with BFA (5/~g/ml) for 
1 min at 37°C, rinsed with three 1-ml  changes of media and then placed in 1 ml of fresh media at 37°C for the indicated recovery times. 
Cells were then fixed, permeab~,  and prepared for indirect immunofluorescence  with antibodies to Man H and the ll0-kD protein. 
After 1 rain of BFA treatment, the ll0-kD protein had dissociated from the Golgi apparatus and was distributed throughout the cytoplasm, 
while no obvious change in Golgi morphology,  labeled by Man II, was evident.  But after removal of BFA and 5 min of recovery in the 
absence of drug, Man II was now found distributed both in an ER pattern and in residual Golgi-like structures.  The ll0-kD protein shifted 
from a widely dispersed distribution after the l-min BFA treatment to a pattern that appeared to colocalize with the Man II staining. By 
15 min of recovery the Man II stainin~ appeared  again within a Golgi structure that colocalized  with the ll0-kD protein. Bar,  1O pm. 
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n  ocodazole  treatment  on the 
BFA-indueed dissociation  of 
the ll0-kD protein. NRK cells 
were either treated at 16"C in 
the  absence  or  presence  of 
BF/~ (5  t~g/ml) for  30  min 
(first and second rows) or at 
37"C were preincubated with 
nocodazole (NZ) 20 ~g/ml) for 
2 h  and then  incubated with 
nocodazole, in the absence or 
presence of  BFA (5/~g/ml) for 
30 rain (third  and  fourth rows) 
before preparation  for immu- 
nofluorescence. At 16°C Man 
H-labeled  Golgi  structures 
and its colocalization with the 
ll0-kD protein  staining  pat- 
tern was  similar  to that  ob- 
served in 37°C control cells. 
The addition of BFA to these 
cells  at  16°C, however, re- 
suited  in  the  release  of the 
110-kD protein from the Golgi 
complex,  while  Man II was 
inhibited from moving beyond 
short  tubuiovesicular  struc- 
tures into the ER. Nocodazole 
treatment  (third and fourth 
rows) resulted in the fragmen- 
tation and dispersion of Man 
H-iabeled Golgi elements but 
the ll0-kD protein  remained 
colocaiized  with  each  Golgi 
fragment.  Subsequent  treat- 
ment of these ceils with BFA 
resulted  in the release of the 
ll0-kD  protein  but  Man  II 
staining  remained  as  frag- 
mented Golgi structures. Bar, 
10 ~m. 
reformed directly from the fragments themselves or, in part, 
required the Golgi apparatus to enter the ER before refor- 
mation. 
ATP Depletion Disrupts the 110-kD Protein-Golgi 
Apparatus Association 
Other agents known to inhibit BFA-induced redistribution 
of  Golgi  apparatus  into  the  ER  are  metabolic  poisons 
(Lippincott-Schwartz et al.,  1989).  In our attempt to deter- 
mine if these agents could inhibit the dissociation of the 110- 
kD protein from the Golgi apparatus in BFA-treated cells, we 
found that ATP depletion alone caused the release of the 110- 
kD protein. Within 5 rnin after treating cells with 2-deoxy- 
glucose and sodium azide to lower cellular ATP levels, the 
ll0-kD protein was released and found diffusely distributed 
throughout the cytoplasm while the Golgi apparatus struc- 
ture remained intact (Fig.  7).  Removal of 2-deoxyglucose 
and sodium azide resulted in the re,  association of the ll0-kD 
protein with the Golgi apparatus.  At no time during ATP 
depletion or subsequent recovery was there any evidence of 
Golgi proteins redistributing to the ER. 
This effect of ATP depletion further distinguishes the ll0- 
kD protein from the  other known Golgi peripheral mem- 
brane proteins shown in Fig. 2. While the association of the 
ll0-kD  protein  with  the  Golgi  apparatus  was  dependent 
upon the presence of ATP,  the Golgi staining pattern pro- 
duced by the antibodies directed  against either the  58-kD 
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maintain the association  of  the 
ll0-kD protein with the Gol- 
gi apparatus. Cells were un- 
treated (Control),  incubated 
for 5 rain at 37°C in the pres- 
ence of 50 mM 2-deoxyglu- 
cose, and 0.05  % sodium azide 
(DOG/Azide) to deplete cellu- 
lax ATE  or incubated for 5 
rain in DOG/Azide followed 
by 5 rain recovery  in fresh me- 
dia not containing  DOG/Azide 
(Recovery), and then prepared 
for  indirect  immunofluores- 
cence. 5 rain of incubation in 
ATP-depleting media caused 
the  complete dissociation of 
the  ll0-kD protein from the 
Golgi apparatus (DOG/Azide), 
while Golgi positioning  within 
the cell remained unchanged. 
Once the ATP-depleting me- 
dia was removed (Recovery), 
the ll0-kD protein was once 
again  observed colocalized 
with Man n staining in an in- 
tact Golgi structure with no 
evidence of any Man n within 
the ER. Bar, 10/~m. 
protein or the 54- and 86-kD proteins was not affected by in- 
cubation  in  2-deoxyglucose and  sodium  azide  (data  not 
shown). 
Discussion 
The drug BFA has remarkable effects on the structure and 
identity of the Golgi apparatus. Current data suggest that the 
effects of this drug are relatively specific to this organelle. 
Thus, BFA does not alter the morphology of  other organeUes 
and does not inhibit a  variety of organellar processes in- 
cluding endocytosis (Misumi et al.,  1986)  and delivery of 
endocytosed material to lysosomes (Misumi et al.,  1986), 
cell-mediated cytotoxicity (Nuchtern et al., 1989),  and bio- 
synthesis  of proteins  (Misumi  et  al.,  1986;  Ulmer  and 
Palade,  1989).  The  efficacy of BFA at concentrations of 
10-7-10  -8 M  suggests it is binding to a high affinity target 
site (our unpublished observations). Numerous sites of ac- 
tion of the drug could be proposed to explain the phenotypic 
changes to the Golgi apparatus. However, we favor the Golgi 
apparatus itself as a likely target of action. 
In the absence of any direct evidence as to its molecular 
target,  we asked whether any structural alterations at the 
Golgi  apparatus  could  be  detected  that  were  rapid  and 
preceded the morphological changes previously observed. 
The  interaction  of  the  Golgi  apparatus  with  organelle- 
specific structural proteins provided an attractive starting 
point.  Two  known  candidates  are  the  110- and  58-kD 
microtubule-binding proteins described by Allan and Kreis 
(1986) and Bloom and Brashear (1989),  respectively. How- 
ever, only the ll0-kD protein proved to be affected by BFA. 
Within 30 s of the addition of the drug to the medium, this 
protein loses its association with the Golgi apparatus and is 
found diffusely distributed throughout the cells. This effect 
is rapidly reversed upon removal of  BFA. Several lines of  evi- 
dence point to this as a proximal event to the disassembly 
of  the Golgi complex. First, it occurs before any morphologi- 
cal changes in Golgi structure can be appreciated by im- 
munofluorescence. Second, manipulations that inhibit the 
disassembly of  the Golgi apparatus such as lowered tempera- 
ture, nocodazole, and griseofulvin all appear to act either 
subsequent to or independent of the ability of BFA to induce 
the ll0-kD protein dissociation. 
Brief incubation with BFA (<1 min) results in the dissocia- 
tion of at least a significant portion of the ll0-kD protein, 
as defined by immunofluorescence. Removal of BFA within 
this time results in the reassociation of the ll0-kD protein 
with the Golgi apparatus without movement of Golgi pro- 
teins into the ER. In contrast, after longer times of treatment 
with BFA, upon removal of the drug, movement of at least 
some Golgi proteins into the ER is observed before the Golgi 
complex appears  normal,  as assessed by immunofluores- 
cence.  The  ll0-kD protein reassociates with Golgi mem- 
brane almost immediately upon removal of BFA. This reas- 
sociation is not limited to Golgi-like structures but will occur 
wherever Golgi proteins are distributed, including the ER. 
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directly binds to Golgi membrane components and that BFA 
prevents this association. Consistent with this,  the ll0-kD 
protein  does  not  appear  to  form  a  scaffold  around  the 
microtubule-organizing  center upon which the Golgi com- 
plex is rebuilt, but rather appears to hind to Golgi proteins 
themselves first. 
Several lines of evidence suggest that the interaction of the 
ll0-kD protein with the Golgi apparatus may be regulated 
by factors other than BFA. First, lowering cellular ATP lev- 
els results in the release  of the protein.  This sensitivity  to 
ATP suggests  that the ll0-kD protein interaction  with the 
Golgi apparatus requires an ATP-binding event and/or phos- 
phorylation.  Second, we have observed diffuse,  non-Golgi 
staining of the 110-kD protein in normal cells that are under- 
going mitosis (data not shown) suggesting that the dissocia- 
tion of this protein may participate in the cell cycle-depen- 
dent  changes  in  Golgi  structure.  Despite  the  apparently 
similar effects of BFA and ATP depletion on the localization 
of the  ll0-kD  protein,  ATP depletion does not result  in 
redistribution of Golgi membrane into the ER. Furthermore, 
ATP depletion itself blocks the ability of BFA to induce the 
redistribution of Golgi proteins into the ER. Therefore, it is 
most likely  that ATP is required by the cell to undergo the 
membrane  transport events subsequent to the ll0-kD dis- 
sociation. 
It will be important to determine the biochemical basis of 
how BFA  interferes  with  the  interaction  of the  110  kD- 
protein with the Golgi apparatus. If we accept the possibility 
that this interaction is a dynamic one, then it is reasonable 
to ask whether BFA is indeed causing the release of the 110- 
kD protein or inhibiting its reassociation.  If the latter were 
the case then the time course of the effect of BFA would indi- 
cate a rapid cycle of association/dissociation of the ll0-kD 
protein with the Golgi apparatus. The association/dissocia- 
tion of protein components between the Golgi apparatus and 
the cytosol has been proposed as part of the vesicular trans- 
port cycle by Orci et al. (1989). BFA may affect the associa- 
tion  of the  ll0-kD  protein  with  the  Golgi  apparatus by 
directly interacting with the protein or its binding site on the 
Golgi apparatus. Alternatively, BFA may alter the biochem- 
istry of the ll0-kD protein or proteins with which it inter- 
acts;  e.g.,  by altering phosphorylation patterns.  Whatever 
the details,  these studies suggest that in BFA-treated cells 
specific biochemical changes at the level of the Golgi appara- 
tus result in abrogation of anterograde transport and the dis- 
assembly of the Golgi apparatus. 
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